Product logins

Find logins to all Clarivate products below.


ENT Devices – Market Insights – Asia Pacific (Supplemental)

Driven by the increasing prevalence of ear, nose, and throat disease and patient awareness of ENT procedures in this region, the Asia Pacific ENT device market will continue to expand through 2033, despite the competition from nonsurgical alternative treatments, such as antibiotics. Moreover, there will be increasing adoption of innovative and premium-priced products, such as flexiblescopes, RF handpieces, and powered instruments; as a result, the Asia Pacific market for ENT devices will grow at a modest pace.

This Medtech 360 Report provides high-level market metrics for ENT devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the region from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Video and High-Tech Hardware Devices – Market Insights – United States
The US video and high-tech hardware device market will experience modest expansion through 2035. This growth is primarily driven by the increasing adoption of articulated surgical robotic systems…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…